Literature DB >> 8037993

Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated with captopril.

S Wieshammer1, M Hetzel, J Hetzel, M Kochs, V Hombach.   

Abstract

OBJECTIVE: To test the hypothesis that the addition of nitrates improves exercise tolerance in patients with heart failure caused by coronary artery disease already treated with an angiotensin converting enzyme inhibitor and diuretics.
DESIGN: Randomised, double blind, placebo controlled, 16 week treatment periods.
SETTING: Outpatient clinic at a university hospital. PATIENTS: 54 patients with previous myocardial infarction, symptoms of mild to moderate heart failure, left ventricular ejection fraction below 40%, no exercise-induced angina or electrocardiographic signs of ischaemia. Four patients in the nitrate group (n = 24) and one patient of the placebo group (n = 25) were withdrawn from the study. INTERVENTION: After the patients had been on constant doses of captopril and diuretics for at least 2 weeks, they were randomised to receive a target dose of 40 mg isosorbide dinitrate twice daily or placebo in addition to the continuation of captopril and diuretics. MEASUREMENTS: Bicycle exercise tests with measurement of gas exchange were carried out before randomisation and after 1, 6, 12, and 16 weeks of the double blind treatment. The change in peak oxygen uptake from control to week 16 was prospectively defined as the main outcome measure.
RESULTS: The increase in peak oxygen uptake from before randomisation tended to be greater in the placebo group (before randomisation 17.4 (3.4) ml/min/kg) than in the nitrate group (before randomisation 17.1 (3.5) ml/min/kg) after 12 weeks (mean increase 1.1 (2.7) v 0.0 (2.7) ml/min/kg, p < 0.12) and 16 weeks (1.7 (3.0) v 0.3 (2.6) ml/min/kg, p < 0.14) of treatment.
CONCLUSION: The addition of nitrates to a baseline treatment consisting of captopril and diuretics did not improve exercise tolerance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8037993      PMCID: PMC1025223          DOI: 10.1136/hrt.70.1.17

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  25 in total

1.  ACE inhibitors--a cornerstone of the treatment of heart failure.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators.

Authors:  W H van Gilst; P A de Graeff; M J de Leeuw; E Scholtens; H Wesseling
Journal:  J Cardiovasc Pharmacol       Date:  1991-09       Impact factor: 3.105

3.  Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.

Authors:  N Dakak; N Makhoul; M Y Flugelman; A Merdler; H Shehadeh; A Schneeweiss; D A Halon; B S Lewis
Journal:  Am J Cardiol       Date:  1990-09-01       Impact factor: 2.778

4.  Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.

Authors:  J A Franciosa; S R Goldsmith; J N Cohn
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

5.  Captopril does not prevent nitroglycerin tolerance in heart failure.

Authors:  J Dupuis; G Lalonde; D Bichet; J L Rouleau
Journal:  Can J Cardiol       Date:  1990-09       Impact factor: 5.223

6.  Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure.

Authors:  N P Buller; P A Poole-Wilson
Journal:  Br Heart J       Date:  1990-05

7.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G S Francis; C Benedict; D E Johnstone; P C Kirlin; J Nicklas; C S Liang; S H Kubo; E Rudin-Toretsky; S Yusuf
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

8.  Prevention of nitrate tolerance with angiotension converting enzyme inhibitors.

Authors:  R J Katz; W S Levy; L Buff; A G Wasserman
Journal:  Circulation       Date:  1991-04       Impact factor: 29.690

9.  Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.

Authors:  J A Franciosa; J N Cohn
Journal:  Am J Cardiol       Date:  1979-05       Impact factor: 2.778

10.  Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure.

Authors:  J G Cleland; E Henderson; J McLenachan; I N Findlay; H J Dargie
Journal:  J Am Coll Cardiol       Date:  1991-03-01       Impact factor: 24.094

View more
  2 in total

Review 1.  Optimising heart failure pharmacotherapy: the ideal combination.

Authors:  J G Cleland; D P Dutka
Journal:  Br Heart J       Date:  1994-08

Review 2.  Medical treatment beyond ACE inhibition: false promise or lack of vision?

Authors:  J T Walsh; A J Cowley
Journal:  Br Heart J       Date:  1994-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.